Upload vanminh
View 215
Download 0
Embed Size (px) 344 x 292 429 x 357 514 x 422 599 x 487
Citation preview
APPLICATION NUMBER: 21-983 PROPRIETARY NAME REVIEW(S)€¦ · APPLICATION NUMBER: 21-983 PROPRIETARY NAME REVIEW(S) FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research
Novo Nordisk's Victoza FDA CDER Proprietary Name Review
Proprietary Name Review(s) · 2019. 12. 4. · review on December 14, 2018. 1.2 PRODUCT INFORMATION The following product information is provided in the proprietary name submission
Report on the Deliberation Results Non-proprietary Name
206334Orig1s000 · 2014-03-03 · This review evaluates the proposed proprietary name, Orbactiv, from a safety and promotional perspective. The sources and methods used to evaluate
Geography & Terms Review Name and Hour Save as Geo Review your Name
PDUFA Pilot Project: Proprietary Name Review · PDF fileConcept Paper PDUFA Pilot Project Proprietary Name Review I. INTRODUCTION On September 27, 2007, President Bush signed into
Janage proprietary drug name personality profile-2
125418Orig1s000 - Food and Drug Administration...125418Orig1s000 PROPRIETARY NAME REVIEW(S) 4 of 4 ... Stedman's Medical Dictionary, 26th ed. 1995, at 1292. Reference ID: 3165699 (b)
Guide to Online International Non-Proprietary Name (INN) Electronic Name Submission Process
International Non-proprietary Name: Imipenem monohydrate
CENTER FOR DRUG EVALUATION AND RESEARCH...1 INTRODUCTION This review evaluates the proposed proprietary name, Axumin, from a safety and misbranding perspective. The sources and methods
Report on the Deliberation Results4 Review Report (1) June 28, 2013 I. Product Submitted for Registration [Brand name] Vyndaqel Capsules 20 mg [Non-proprietary name] Tafamidis Meglumine
International Non-proprietary Name: bazedoxifene Procedure No
PROPRIETARY NAME REVIEW~ · sound-alike confusion with Verdeso are Vantas, Verelan, Vidaza, Videx, Viread, Virilon and'-- *** Additionally, DMETS conducted prescription studies to
PROPRIETARY NAME AND DOSAGE FORM
International non-proprietary name: apalutamide Procedure No. … · International non-proprietary name: apalutamide . Procedure No. EMEA/H/C/004452/II/0001 . Marketing authorisation
210737Orig1s000 210737Orig2s000 PROPRIETARY NAME ......Thus, Cumberland Pharmaceuticals Inc. resubmitted the proposed proprietary name, RediTrex, for review. 2 METHODS AND DISCUSSION
205787Orig1s000 - Food and Drug Administration · 205787Orig1s000 PROPRIETARY NAME REVIEW(S) Department of Health and Human Services Public Health Service . Food and Drug Administration
PROPRIETARY NAME REVIEW(S) · 2.2.1 United States Adopted Names (USAN) Search There is no USAN stem present in the proposed proprietary name.4 2.2.2 Components of the Proposed Proprietary
[INSERT YOUR NAME HERE] Campaign Overview. Proprietary and Confidential2 The Problem
Region Name Review
International non-proprietary name: USTEKINUMAB · PDF fileInternational non-proprietary name: USTEKINUMAB Procedure No. EMEA/H/C/000958/II/0029 Note Variation assessment report as
LIST OF PROPRIETARY FIRMS WITH NEW … · LIST OF PROPRIETARY FIRMS WITH NEW REGISTRATION NUMBER. MEMBER NO NAME FIRM NAME NEW REGNNO 8407 Bibhuti Bhusan Nath B …
Doc Name – 1 Telcordia Technologies Proprietary - Internal use only. See proprietary restrictions on title page. The Scholars BALD heads forgetful of
022458Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 022458orig1s000 proprietary name review(s)
PROPRIETARY NAME REVIEW~ · 2009. 9. 30. · proposed product: the proposed proprietary name (Sancuso), the established name (granisetron), proposed indication (the prevention of
Confidential & Proprietary Copyright © 2010 The Nielsen Company Region Name Review Name Date
International non-proprietary name: solriamfetol Procedure
PROPRIETARY NAME REVIEW(S)Mar 22, 2010 · Applicant’s intended pronunciation of the proprietary name (i sop ‘to kar pen) was provided and taken into consideration. 2.2 MEDICATION
![Report on the Deliberation Results4 Review Report (1) June 28, 2013 I. Product Submitted for Registration [Brand name] Vyndaqel Capsules 20 mg [Non-proprietary name] Tafamidis Meglumine](https://img.dokumen.tips/doc/110x75/5f25fba54f6a4c5b68310287/report-on-the-deliberation-results-4-review-report-1-june-28-2013-i-product.jpg)
![[INSERT YOUR NAME HERE] Campaign Overview. Proprietary and Confidential2 The Problem](https://img.dokumen.tips/doc/110x75/5697bff41a28abf838cbcc73/insert-your-name-here-campaign-overview-proprietary-and-confidential2-the.jpg)
